NCT04434300View on ClinicalTrials.gov

Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

January 15, 2021

Study Completion Date

November 15, 2021

Conditions
AntibioticsSubcutaneous InjectionDaptomycin
Interventions
DRUG

Daptomycin

Compare the pharmacokinetic of subcutaneous (SC) and intravenous (IV) routes in the same patient.

DRUG

Daptomycin

Compare the pharmacokinetic of subcutaneous (SC) and intravenous (IV) routes in the same patient.

Trial Locations (1)

14000

CHU Caen, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT04434300 - Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC) | Biotech Hunter | Biotech Hunter